Global Vertigo Clinical Trials Review, H2, 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vertigo Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

Vertigo Global Clinical Trials Review, H2, 2016 provides an overview of Vertigo clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision-making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Tables & Figures
  2. Report Guidance
  3. Clinical Trials by Region
  4. Clinical Trials and Average Enrollment by Country
  5. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  6. Top Five Countries Contributing to Clinical Trials in Europe
  7. Top Countries Contributing to Clinical Trials in North America
  8. Top Countries Contributing to Clinical Trials in Middle East and Africa
  9. Top Countries Contributing to Clinical Trials in Central and South America
  10. Clinical Trials by G7 Countries: Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials
  11. Clinical Trials by Phase in G7 Countries
  12. Clinical Trials in G7 Countries by Trial Status
  13. Clinical Trials by E7 Countries: Proportion of Vertigo to Ear Nose Throat Disorders Clinical Trials
  14. Clinical Trials by Phase in E7 Countries
  15. Clinical Trials in E7 Countries by Trial Status
  16. Clinical Trials by Phase
  17. In Progress Trials by Phase
  18. Clinical Trials by Trial Status
  19. Clinical Trials by End Point Status
  20. Subjects Recruited Over a Period of Time
  21. Clinical Trials by Sponsor Type
  22. Prominent Sponsors
  23. Top Companies Participating in Vertigo Therapeutics Clinical Trials
  • Abbott Laboratories
  • Dr. Willmar Schwabe GmbH & Co. KG
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Sensorion S.A.
  • Laboratoires Pierre Fabre SA
  • Eisai Co., Ltd.
  • Cipla Ltd.
  • Buffalo ENT Specialists, LLP
  • Apsen Farmaceutica SA
  • Amdipharm Mercury Company Limited

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/krp98c/vertigo_global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials